Lv5
1240 积分 2021-05-30 加入
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial
7小时前
待确认
Value of a 21-gene expression assay on core biopsy to predict neoadjuvant chemotherapy response in breast cancer: systematic review and meta-analysis
2年前
已完结
Value of a 21-gene expression assay on core biopsy to predict neoadjuvant chemotherapy response in breast cancer: systematic review and meta-analysis
2年前
已完结
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
2年前
已完结
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
2年前
已完结
Evolution of low HER2 expression between early and advanced-stage breast cancer
2年前
已完结
Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer
2年前
已完结
Current landscape of personalized clinical treatments for triple-negative breast cancer
2年前
已完结
Homologous recombination deficiency predicts the response to platinum-based neoadjuvant chemotherapy in early-stage triple-negative breast cancer patients: a systematic review and meta-analysis
2年前
已完结
Homologous Recombination Deficiency (HRD) and BRCA 1/2 Gene Mutation for Predicting the Effect of Platinum-Based Neoadjuvant Chemotherapy of Early-Stage Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis
2年前
已完结
皖公网安备34019202002308
